Multiple Myeloma Clinical Trials
Multiple myeloma clinical trials provide patients with exciting opportunities to be among the first to receive and benefit from promising new treatments before those options are widely available in other settings. In doing so, participants also help to accelerate the development of next-generation treatments that will benefit all current and future cancer patients.
The purpose of a clinical trial is to assess the effectiveness of a new treatment in comparison to that of existing treatments. Prior to being used a clinical trial, a new treatment is tested extensively to confirm its safety. Many people assume that placebos are used in cancer clinical trials, but that is not the case. Instead, a participant can expect to receive either a brand-new treatment or the current “best standard” treatment that is currently available.
At Moffitt Cancer Center, we perform extensive research and have an active multiple myeloma clinical trials program. Our scientists and clinicians are currently evaluating:
- Drug therapies to control myeloma or alleviate symptoms
- Stem cell transplants used in combination with high-dose chemotherapy
- Biphosphonates for treating bone complications that often accompany multiple myeloma
- Radiation therapy to destroy the cancer cells or inhibit their growth
- Surgical techniques designed to repair fractures, manage pain and improve function and mobility
As the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, Moffitt continues to lead the way in cancer research. Our multiple myeloma clinical trials are transforming the treatment landscape by eliminating obstacles and speeding up every step of the drug research and development process. These important research studies are the most reliable scientific method for determining whether a new treatment works better than the current standard of care.
To learn more about the multiple myeloma clinical trials currently underway at Moffitt, call 1-888-663-3488 or complete a new patient registration form. We can help you determine whether you qualify for one of our trials, and we do not require referrals.